Accommodation of grafts: Implications for health and disease

Human Immunology

Volumn 68, Issue 8, 2007, Pages 645-651

  Tang, Amy H ^a,b   Platt, Jeffrey L ^a,b  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Accommodation; Allotransplantation; Blood groups; Humoral rejection; Xenotransplantation

Indexed keywords

CD59 ANTIGEN; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 13; INTERLEUKIN 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANTIBODY PRODUCTION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CELL PROTECTION; DELAYED HYPERSENSITIVITY; GRAFT ACCOMMODATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HOST VS GRAFT REACTION; HUMANS; IMMUNE TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547152022     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.04.003     Document Type: Article

References (79)

1. Cascalho M. Accommodation. Am J Transplant, in press.
2. Koch C.A., Khalpey Z.I., and Platt J.L. Accommodation: preventing injury in transplantation and disease. J Immunol 172 (2004) 5143
3. King K.E., Warren D.S., Samaniego-Picota M., Campbell-Lee S., Montgomery R.A., and Baldwin III W.M. Antibody, complement and accommodation in ABO-incompatible transplants. Curr Opin Immunol 16 (2004) 545
4. Bannett A.D., McAlack R.F., Raja R., Baquero A., and Morris M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 19 (1987) 4543
5. Bannett A.D., McAlack R.F., Morris M., Chopek M., and Platt J.L. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 21 (1989) 783
6. Gleason R.E., and Murray J.E. Report from kidney transplant registry: analysis of variables in the function of human kidney transplants. Transplantation 5 (1967) 3437
7. Wilbrandt R., Tung K.S.K., Deodhar S.D., Nakamoto S., and Kolff W.J. ABO blood group incompatibility in human renal homotransplantation. Am J Clin Pathol 51 (1969) 15
8. Alexandre G.P.J., Squifflet J.P., De Bruyere M., Latinne D., Moriau M., Ikabu N., et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 17 (1985) 138
9. Alexandre G.P.J., Squifflet J.P., De Bruyere M., Latinne D., Reding R., Gianello P., et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 19 (1987) 4538
10. Parker W., Lundberg-Swanson K., Holzknecht Z.E., Lateef J., Washburn S.A., Braedehoeft S.J., et al. Isohemagglutinins and xenoreactive antibodies are members of a distinct family of natural antibodies. Hum Immunol 45 (1996) 94
11. Platt J.L., Vercellotti G.M., Dalmasso A.P., Matas A.J., Bolman R.M., Najarian J.S., et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 11 (1990) 450
12. Platt J.L., Fischel R.J., Matas A.J., Reif S.A., Bolman R.M., and Bach F.H. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52 (1991) 214
13. Takemoto S.K., Zeevi A., Feng S., Colvin R.B., Jordan S., Kobashigawa J., et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4 (2004) 1033
14. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff'05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7 (2007) 518
15. Pelletier R.P., Hennessy P.K., Adams P.W., and Orosz C.G. High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Am J Transplant 2 (2002) 9262
16. Adeyi O.A., Girnita A.L., Howe J., Marrari M., Awadalla Y., Askar M., et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 14 (2005) 53
17. Zhang Q., Liang L.W., Gjertson D.W., Lassman C., Wilkinson A.H., Kendrick E., et al. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 79 (2005) 591
18. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5 (2005) 2265
19. Vasilescu E.R., Ho E.K., Colovai A.I., Vlad G., Foca-Rodi A., Markowitz G.S., et al. Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 67 (2006) 597
20. Lefaucheur C., Nochy D., Hill G.S., Suberbielle-Boissel C., Antoine C., Charron D., et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 7 (2007) 832
21. Parker W., Bruno D., and Platt J.L. Xenoreactive natural antibodies in the world of natural antibodies: typical or unique?. Transpl Immunol 3 (1995) 181
22. Cascalho M., and Platt J.L. Xenotransplantation and other means of organ replacement. Nat Rev Immunol 1 (2001) 154
23. Lin S.S., Weidner B.C., Byrne G.W., Diamond L.E., Lawson J.H., Hoopes C.W., et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 101 (1998) 17458
24. Lin S.S., Hanaway M.J., Gonzalez-Stawinski G.V., Lau C.L., Parker W., Davis R.D., et al. The role of anti-Gala1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 70 (2000) 1667
25. Lin S.S., Kooyman D.L., Daniels L.J., Daggett C.W., Parker W., Lawson J.H., et al. The role of natural anti-Gala1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transplant Immunol 5 (1997) 2127
26. Lin S.S., and Platt J.L. The role of immunoabsorption in xenotransplantation. In: Brunkhorst R., Koch K.M., and Koll R. (Eds). Klinische immunadsorption (2000), Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 133
27. McCurry K.R., Parker W., Cotterell A.H., Weidner B.C., Lin S.S., Daniels L.J., et al. Humoral responses in pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 58 (1997) 91
28. Platt J.L. C4d and the fate of organ allografts. J Am Soc Nephrol 13 (2002) 2417
29. Cozzi E., Bosio E., Seveso M., Vadori M., and Ancona E. Xenotransplantation-current status and future perspectives. Br Med Bull 75-76 (2005) 99
30. Koch C.A., Jordan C.E., and Platt J.L. Complement-dependent control of teratoma formation by embryonic stem cells. J Immunol 177 (2006) 4803
31. Dalmasso A.P., Vercellotti G.M., Fischel R.J., Bolman R.M., Bach F.H., and Platt J.L. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 140 (1992) 1157
32. Parker W., Holzknecht Z.E., Song A., Blocher B.A., Bustos M., Reissner K.J., et al. Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation. Am J Pathol 152 (1998) 829
33. Lin S.S., Parker W., Everett M.L., and Platt J.L. Differential recognition by proteins of a-galactosyl residues on endothelial cell surfaces. Glycobiology 8 (1998) 433
34. Parker W., Stitzenberg K.B., Yu P.B., Pratt V.S.W., Nakamura Y.C., Farel L.S., et al. Biophysical characteristics of anti-Gala1-3Gal IgM binding to cell surfaces: implications for xenotransplantation. Transplantation 71 (2001) 4401
35. Yu P.B., Holzknecht Z.E., Bruno D., Parker W., and Platt J.L. Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 157 (1996) 51636
36. Mohiuddin M.M., Ogawa H., Yin D.P., Shen J., and Galili U. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation 75 (2003) 258
37. Yu P.B., Parker W., Nayak J.V., and Platt J.L. Sensitization with xenogeneic tissues alters the heavy chain repertoire of human anti-Galalpha1-3Gal antibodies. Transplantation 80 (2005) 102
38. Ulfvin A., Backer A.E., Clausen H., Hakomori S., Rydberg L., Samuelsson B.E., et al. Expression of glycolipid blood group antigens in single human kidneys: change in antigen expression of rejected ABO incompatible kidney grafts. Kidney Int 44 (1993) 1289
39. Yuzawa Y., Brentjens J.R., Brett J., Caldwell P.R.B., Esposito C., Fukatsu A., et al. Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. J Immunol 150 (1993) 5633
40. Andres G., Yamaguchi N., Brett J., Caldwell P.R.B., Godman G., and Stern D. Cellular mechanisms of adaptation of grafts to antibody. Transpl Immunol 4 (1996) 1
41. Parker W., Lin S.S., and Platt J.L. Antigen expression in xenotransplantation: how low must it go?. Transplantation 71 (2001) 313
42. Everett M.L., Lin S.S., Worrell S.S., Platt J., and Parker W. The footprint of antibody bound to pig cells: evidence of complex surface topology. Biochem Biophys Res Commun 301 (2003) 751
43. Nath K.A., Balla G., Vercellotti G.M., Balla J., Jacob H.S., Levitt M.D., et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90 (1992) 267
44. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 3 (1997) 196
45. Hancock W.W., Buelow R., Sayegh M.H., and Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4 (1998) 13928
46. Delikouras A., Hayes M., Malde P., Lechler R.I., and Dorling A. Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from TNFa-mediated apoptosis in porcine endothelial cells after exposure to low concentrations of xenoreactive natural antibody. Transplantation 71 (2001) 599
47. Jindra P.T., Zhang X., Mulder A., Claas F., Veale J., Jin Y.P., et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 82 (2006) S33
48. Holzknecht Z.E., Kuypers K.L., Plummer T.B., Williams J., Bustos M., Gores G.J., et al. Apoptosis and cellular activation in the pathogenesis of acute vascular rejection. Circ Res 91 (2002) 1135
49. Saadi S., Takahashi T., Holzknecht R.A., and Platt J.L. Pathways to acute humoral rejection. Am J Pathol 164 (2004) 10734
50. Park W., Grande J.P., Ninova D., Nath K.A., Platt J.L., Gloor J.M., et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 3 (2003) 952
51. Dalmasso A.P., He T., and Benson B.A. Human IgM xenoreactive antibodies can induce resistance of porcine endothelial cells to complement-mediated injury. Xenotransplantation 3 (1996) 54
52. Dalmasso A.P., Benson B.A., Johnson J.S., Lancto C., and Abrahamsen M.S. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 164 (2000) 3764
53. Grubbs B.C., Benson B.A., and Dalmasso A.P. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement. Xenotransplantation 10 (2003) 387
54. Dorling A, Stocker C, Tsao T, Haskard DO, Lechler RI. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1006;62:1127.
55. Dorling A., Delikouras A., Nohadani M., Polak J., and Lechler R.I. In vitro accommodation of porcine endothelial cells by low dose human anti-pig antibody: reduced binding of human lymphocytes by accommodated cells associated with increased nitric oxide production. Xenotransplantation 5 (1998) 84
56. Diamond L.E., McCurry K.R., Oldham E.R., McClellan S.B., Martin M.J., Platt J.L., et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 61 (1996) 1241
57. Cozzi E., Bhatti F., Schmoeckel M., Chavez G., Smith K.G., Zaidi A., et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 70 (2000) 15
58. Diamond L.E., Quinn C.M., Martin M.J., Lawson J., Platt J.L., and Logan J.S. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 71 (2001) 132
59. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11 (2005) 32
60. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29
61. Grehan J.F., Levay-Young B.K., Fogelson J.L., Francois-Bongarcon V., Benson B.A., and Dalmasso A.P. IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway. J Immunol 175 (2005) 1903
62. Black S.M., Grehan J.F., Rivard A.L., Benson B.A., Wahner A.E., Koch A.E., et al. Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human complement. J Immunol 177 (2006) 7355
63. Koch C.A., Kanazawa A., Nishitai R., Knudsen B.E., Ogata K., Plummer T.B., et al. Intrinsic resistance of hepatocytes to complement-mediated injury. J Immunol 174 (2005) 7302
64. Holzknecht Z.E., and Platt J.L. The fine cytokine line between graft acceptance and rejection. Nat Med 6 (2000) 4970
65. Holzknecht Z.E., and Platt J.L. Accommodation and the reversibility of biological systems. Transplantation 71 (2001) 594
66. Platt J.L., and Nath K.A. Heme oxygenase: protective gene or Trojan horse. Nat Med 4 (1998) 1364
67. Daborn P.J., Yen J.L., Bogwitz M.R., Le Goff G., Feil E., Jeffers S., et al. A single p450 allele associated with insecticide resistance in Drosophila. Science 297 (2002) 2253
68. Kuruganti S., Lam V., Zhou X., Bennett G., Pittendrigh B.R., and Ganguly R. High expression of Cyp6g1, a cytochrome P450 gene, does not necessarily confer DDT resistance in Drosophila melanogaster. Gene 388 (2007) 43
69. Carney D.F., Lang T.J., and Shin M.L. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J Immunol 145 (1990) 623
70. Marchbank K.J., Van Den Berg C.W., and Morgan B.P. Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrest. Immunology 90 (1997) 647
71. Narayanan K., Jendrisak M.D., Phelan D.L., and Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transplant Immunol 15 (2006) 187
72. Smith R.N., Kawai T., Boskovic S., Nadazdin O., Sachs D.H., Cosimi A.B., et al. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates. Am J Transplant 6 (2006) 1790
73. Segev D.L., Simpkins C.E., Warren D.S., King K.E., Shirey R.S., Maley W.R., et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 5 (2005) 2570
74. Stussi G., Halter J., Schanz U., and Seebach J.D. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfus Apher Sci 35 (2006) 59
75. Stussi G., West L., Cooper D.K., and Seebach J.D. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplantation 13 (2006) 390
76. Warner P.R., and Nester T.A. ABO-incompatible solid-organ transplantation. Am J Clin Pathol 125 Suppl (2006) S87
77. Lin Y., Vandeputte M., and Waer M. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 160 (1998) 369
78. Ogawa H., Mohiuddin M.M., Yin D.P., Shen J., Chong A.S., and Galili U. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation 77 (2004) 366
79. Fan X., Ang A., Pollock-BarZiv S.M., Dipchand A.I., Ruiz P., Wilson G., Platt J.L., et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 10 (2004) 1227